Don (Dong-Hun) Lee is a Principal Scientist at Merck, where they have contributed to the development and validation of numerous immunoassays and supported three FDA-approved drugs. Previously, they were a Scientist at the New York Blood Center from 1990 to 2005, playing a key role in submitting an IND to the FDA for NAT testing for West Nile Virus and developing innovative nucleic acid extraction systems. Don is currently pursuing a Ph.D. in Biomedical Science at the University of Amsterdam.
This person is not in the org chart
This person is not in any teams
This person is not in any offices